[go: up one dir, main page]

Reva et al., 2020 - Google Patents

Erythrocytes as a target of SARS CoV-2 in pathogenesis of COVID-19

Reva et al., 2020

View PDF
Document ID
8347692049668020412
Author
Reva I
Yamamoto T
Rasskazova M
Lemeshko T
Usov V
Krasnikov Y
Fisenko A
Kotsyurbiy E
Tudakov V
Tsegolnik E
Oleksenko O
Korobkin A
Slabenko E
Shindina A
Gordzievskaya K
Furgal A
Reva G
Publication year
Publication venue
Archiv EuroMedica

External Links

Snippet

The paper considers the possible mechanism of the pathogenesis of COVID-19 caused by SARSCOV-2, associated with damage to red blood cells, which the authors attribute to the main key target that triggers a cascade of reactions leading to multiple organ failure. The …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides

Similar Documents

Publication Publication Date Title
Reva et al. Erythrocytes as a target of SARS CoV-2 in pathogenesis of COVID-19
Paolini et al. Cell death in coronavirus infections: Uncovering its role during COVID-19
JP5923167B2 (en) Use of andrographolide C15 substituted series derivatives for the preparation of anti-hepatitis B drugs
CN101744830B (en) Flavonoid compound and application of plant extract containing same
CN106727482B (en) Application of 1,8-dihexanoyl-emodin in the preparation of anti-HIV-1 drugs
Prabhu et al. Cyanobacterial metabolites as novel drug candidates in corona viral therapies: A review
Pan et al. The inhibitory effect Polygonum Cillinerve polysaccharide on transmissible gastroenteritis virus of swine
CN101695511B (en) Pomegranate rind extract and production method and application thereof
KR20000069296A (en) Extracts of Salvia Species Having Antiviral Activity
CN108635346B (en) 3,3 '-(3,4- dichloro benzylidene)-bis- -4 hydroxy coumarins are used to prepare the application of rabies cytotoxic drug
Chavan History of Hiv & Aids
CN114246847B (en) Application of chalcone compounds in treatment of coronavirus infection
CN103393676B (en) Application of auraptene to preparing medicaments for inhibiting enterovirus 71-type infection
AKANITAPICHAT et al. Inhibitory activities of Thai medicinal plants against herpes simplex type 1, poliovirus type 1, and measles virus
CN101347492A (en) Use of Trigonostemon xyphophylloides extract in preparing anti-AIDS medicament
Chiang et al. Antiviral activity of eight commonly used medicinal plants in Taiwan
RU2741714C1 (en) Sars-cov-2 replication inhibitor based on a water extract of the fungus inonotus obliquus
CN115869324B (en) Application of Efavirennz in preparation of anti-enterovirus drugs
CN101820888A (en) Composition comprising sodium (meta)arsenite for treatment of hepatitis c virus
Das et al. Introspecting Scope of Ultra-Diluted Homeopathic Preparations in Human SARS-CoV-2 Infection: A Perspective Review
Karami A Summary of Effective Management of COVID-19 in Iran Collaboration of Civil and Defense forces
RU2747018C1 (en) Sars-cov-2 coronavirus replication inhibitor based on melanin from inonotus obliquus fungus
Vigbedor et al. Review of four major biomolecular target sites for COVID-19 and possible inhibitors as treatment interventions
CN106214777B (en) anti-HIV-1 virus effective part of potentilla chinensis in northwest China, preparation method and application
Zraikat et al. Study of the Effect of Type 2 Dia-betes on the Immortalization of Human B Lymphocytes